论文部分内容阅读
T_1期膀胱肿瘤的治疗将临床医师置于一进退两难的境地。大部分泌尿外科医师倾向于首先行TUR切除一切肉眼可见的肿瘤,而后进行膀胱灌注治疗,预防其复发。BCG在T_1G_3膀胱癌患者非常成功地减少了疾病的复发和进展,因而被认为是高危表浅性移行细胞癌(TCC)的标准治疗方法。本研究的目的是评价T_1期病理分级较高的TCC患者首先行局部TUR治疗后行BCG膀胱灌注的
Treatment of T 1 bladder cancer places clinicians in a dilemma. Most urologists tend to first TUR resection of all macroscopic tumors, and then bladder irrigation treatment to prevent the recurrence. BCG in T 1 G 3 bladder cancer patients has been very successful in reducing the recurrence and progression of the disease and is therefore considered the standard treatment for high-risk superficial transitional cell carcinoma (TCC). The purpose of this study was to evaluate the efficacy of BCG bladder perfusion after first local TUR treatment of TCC patients with high T 1 pathological grade